IIR launches pharmaceutical expo
Dubai, March 25, 2008
IIR Middle East, the organisers of Arab Health, is launching the first International Pharmaceutical and Biotechnology Exhibition (PABME) in the Middle East.
Designed to be an international destination where business cultures and ideas can meet, PABME is the region’s only event that is being formatted as a major exhibition, with a multi-disciplinary conference running alongside to cater to global markets, said an official spokesman.
Over the past few years, the global pharmaceutical market has shown a consistent growth pattern and the world market for biotechnological drugs is thriving. With its current global market value standing at $460 billion, it is estimated that by 2009, the industry will serge to US$625 billion.
The total value of the Middle East market currently stands in excess of $10 billion and is registering growth rates of 15 to 18 per cent. A huge boom in the biotechnology industry in the region is predicted to occur over the coming years, once again through private and public investment.
“PABME will showcase a wide spectrum of products and services to cater to all businesses associated with the pharmaceutical and biotechnology industries,” said director of Life Sciences at IIR Middle East Simon Page.
“The event will offer companies the perfect opportunity to find new business contacts and gain further recognition worldwide.”
Participants at PABME will get to meet and do business with not only the global key industry decision makers but also the Middle East, one of the world’s fastest growing regions for pharmaceutical manufacturing.
The event is expected to be the preferred destination for all international Pharma and Biotech industries. With non-stop flights from Europe, India, China and North America serving Dubai, companies and participants will be placed at the hub of the pharmaceutical and biotech world.
“This exhibition is like a shot in the arm for Middle East pharmaceutical manufacturers,” said managing director and CEO of Neopharma in the UAE Dr B R Shetty. “Thanks to this unique gathering, companies such as Neopharma now have their own exclusive platform to showcase, share and discuss the region’s world-class manufacturing processes.”
Running alongside the exhibition, the PABME Congress will bring together senior decision makers, scientists, marketers and the sales force to tackle global and regional issues.
The key areas covered in this year’s launch event will include drug discovery, clinical trials and manufacturing through to biologics, devices, global licensing and regulatory aspects.
Delegates attending the PABME conferences will be given the opportunity to discuss what East and West can learn from each other, as well as benefiting from a diverse range of opinions and experiences brought by some of the leading experts in the pharmaceutical and biotechnology business.
In addition to the conferences, an eCTD workshop is being held where attendees can learn about the opportunities the document management system can bring and the constraints and pitfalls to be aware of.
The total system requirements will be explained, as well as the possibility to address them by adding one module at a time, keeping the bigger picture in mind. – TradeArabia News Service
More Health & Environment Stories
- Dubai hospital performs new pinhole surgery
- Al Ain Civil Defence ties up with disabilities centre
- ADWEA strategic partner for water summit
- Conference to focus on HSE issues
- Deadly human MERS virus also infects camels
- Axa Gulf launches medical provider locator
- Saudi medical devices market to hit $1.6bn
- Bahrain clamp on fitness drugs
- UAE experts discuss rare congenital disease
- Wintry storm grips ME, worsens misery of Syrians